Trial
NCT00720096
Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
United States Department of Defense
Condition
Ovarian Cancer
Intervention
Liposomal Doxorubicin
Why stopped
Funds for this project have been spent, and it is thereby terminated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-02